Cardiomyocyte Proliferative Capacity Is Restricted in Mice With Lmna Mutation

LMNA is one of the leading causative genes of genetically inherited dilated cardiomyopathy (DCM). Unlike most DCM-causative genes, which encode sarcomeric or sarcomere-related proteins, LMNA encodes nuclear envelope proteins, lamin A and C, and does not directly associate with contractile function....

Full description

Bibliographic Details
Main Authors: Kenji Onoue, Hiroko Wakimoto, Jiangming Jiang, Michael Parfenov, Steven DePalma, David Conner, Joshua Gorham, David McKean, Jonathan G. Seidman, Christine E. Seidman, Yoshihiko Saito
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
p21
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2021.639148/full
id doaj-0d89c6afb09d4627acf5a4a300eec9b8
record_format Article
spelling doaj-0d89c6afb09d4627acf5a4a300eec9b82021-06-23T04:39:02ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2021-06-01810.3389/fcvm.2021.639148639148Cardiomyocyte Proliferative Capacity Is Restricted in Mice With Lmna MutationKenji Onoue0Kenji Onoue1Hiroko Wakimoto2Jiangming Jiang3Michael Parfenov4Steven DePalma5David Conner6Joshua Gorham7David McKean8Jonathan G. Seidman9Christine E. Seidman10Christine E. Seidman11Yoshihiko Saito12Department of Cardiovascular Medicine, Nara Medical University, Kashihara, JapanDepartment of Genetics, Harvard Medical School, Boston, MA, United StatesDepartment of Genetics, Harvard Medical School, Boston, MA, United StatesDepartment of Genetics, Harvard Medical School, Boston, MA, United StatesDepartment of Genetics, Harvard Medical School, Boston, MA, United StatesDepartment of Genetics, Harvard Medical School, Boston, MA, United StatesDepartment of Genetics, Harvard Medical School, Boston, MA, United StatesDepartment of Genetics, Harvard Medical School, Boston, MA, United StatesDepartment of Genetics, Harvard Medical School, Boston, MA, United StatesDepartment of Genetics, Harvard Medical School, Boston, MA, United StatesDepartment of Genetics, Harvard Medical School, Boston, MA, United StatesDivision of Cardiovascular Medicine, Howard Hughes Medical Institute, Brigham and Women's Hospital, Boston, MA, United StatesDepartment of Cardiovascular Medicine, Nara Medical University, Kashihara, JapanLMNA is one of the leading causative genes of genetically inherited dilated cardiomyopathy (DCM). Unlike most DCM-causative genes, which encode sarcomeric or sarcomere-related proteins, LMNA encodes nuclear envelope proteins, lamin A and C, and does not directly associate with contractile function. However, a mutation in this gene could lead to the development of DCM. The molecular mechanism of how LMNA mutation contributes to DCM development remains largely unclear and yet to be elucidated. The objective of this study was to clarify the mechanism of developing DCM caused by LMNA mutation.Methods and Results: We assessed cardiomyocyte phenotypes and characteristics focusing on cell cycle activity in mice with Lmna mutation. Both cell number and cell size were reduced, cardiomyocytes were immature, and cell cycle activity was retarded in Lmna mutant mice at both 5 weeks and 2 years of age. RNA-sequencing and pathway analysis revealed “proliferation of cells” had the most substantial impact on Lmna mutant mice. Cdkn1a, which encodes the cell cycle regulating protein p21, was strongly upregulated in Lmna mutants, and upregulation of p21 was confirmed by Western blot and immunostaining. DNA damage, which is known to upregulate Cdkn1a, was more abundantly detected in Lmna mutant mice. To assess the proliferative capacity of cardiomyocytes, the apex of the neonate mouse heart was resected, and recovery from the insult was observed. A restricted cardiomyocyte proliferating capacity after resecting the apex of the heart was observed in Lmna mutant mice.Conclusions: Our results strongly suggest that loss of lamin function contributes to impaired cell proliferation through cell cycle defects. The inadequate inborn or responsive cell proliferation capacity plays an essential role in developing DCM with LMNA mutation.https://www.frontiersin.org/articles/10.3389/fcvm.2021.639148/fulldilated cardiomyopathylamin A/Ccell cyclep21repressed proliferating capacity
collection DOAJ
language English
format Article
sources DOAJ
author Kenji Onoue
Kenji Onoue
Hiroko Wakimoto
Jiangming Jiang
Michael Parfenov
Steven DePalma
David Conner
Joshua Gorham
David McKean
Jonathan G. Seidman
Christine E. Seidman
Christine E. Seidman
Yoshihiko Saito
spellingShingle Kenji Onoue
Kenji Onoue
Hiroko Wakimoto
Jiangming Jiang
Michael Parfenov
Steven DePalma
David Conner
Joshua Gorham
David McKean
Jonathan G. Seidman
Christine E. Seidman
Christine E. Seidman
Yoshihiko Saito
Cardiomyocyte Proliferative Capacity Is Restricted in Mice With Lmna Mutation
Frontiers in Cardiovascular Medicine
dilated cardiomyopathy
lamin A/C
cell cycle
p21
repressed proliferating capacity
author_facet Kenji Onoue
Kenji Onoue
Hiroko Wakimoto
Jiangming Jiang
Michael Parfenov
Steven DePalma
David Conner
Joshua Gorham
David McKean
Jonathan G. Seidman
Christine E. Seidman
Christine E. Seidman
Yoshihiko Saito
author_sort Kenji Onoue
title Cardiomyocyte Proliferative Capacity Is Restricted in Mice With Lmna Mutation
title_short Cardiomyocyte Proliferative Capacity Is Restricted in Mice With Lmna Mutation
title_full Cardiomyocyte Proliferative Capacity Is Restricted in Mice With Lmna Mutation
title_fullStr Cardiomyocyte Proliferative Capacity Is Restricted in Mice With Lmna Mutation
title_full_unstemmed Cardiomyocyte Proliferative Capacity Is Restricted in Mice With Lmna Mutation
title_sort cardiomyocyte proliferative capacity is restricted in mice with lmna mutation
publisher Frontiers Media S.A.
series Frontiers in Cardiovascular Medicine
issn 2297-055X
publishDate 2021-06-01
description LMNA is one of the leading causative genes of genetically inherited dilated cardiomyopathy (DCM). Unlike most DCM-causative genes, which encode sarcomeric or sarcomere-related proteins, LMNA encodes nuclear envelope proteins, lamin A and C, and does not directly associate with contractile function. However, a mutation in this gene could lead to the development of DCM. The molecular mechanism of how LMNA mutation contributes to DCM development remains largely unclear and yet to be elucidated. The objective of this study was to clarify the mechanism of developing DCM caused by LMNA mutation.Methods and Results: We assessed cardiomyocyte phenotypes and characteristics focusing on cell cycle activity in mice with Lmna mutation. Both cell number and cell size were reduced, cardiomyocytes were immature, and cell cycle activity was retarded in Lmna mutant mice at both 5 weeks and 2 years of age. RNA-sequencing and pathway analysis revealed “proliferation of cells” had the most substantial impact on Lmna mutant mice. Cdkn1a, which encodes the cell cycle regulating protein p21, was strongly upregulated in Lmna mutants, and upregulation of p21 was confirmed by Western blot and immunostaining. DNA damage, which is known to upregulate Cdkn1a, was more abundantly detected in Lmna mutant mice. To assess the proliferative capacity of cardiomyocytes, the apex of the neonate mouse heart was resected, and recovery from the insult was observed. A restricted cardiomyocyte proliferating capacity after resecting the apex of the heart was observed in Lmna mutant mice.Conclusions: Our results strongly suggest that loss of lamin function contributes to impaired cell proliferation through cell cycle defects. The inadequate inborn or responsive cell proliferation capacity plays an essential role in developing DCM with LMNA mutation.
topic dilated cardiomyopathy
lamin A/C
cell cycle
p21
repressed proliferating capacity
url https://www.frontiersin.org/articles/10.3389/fcvm.2021.639148/full
work_keys_str_mv AT kenjionoue cardiomyocyteproliferativecapacityisrestrictedinmicewithlmnamutation
AT kenjionoue cardiomyocyteproliferativecapacityisrestrictedinmicewithlmnamutation
AT hirokowakimoto cardiomyocyteproliferativecapacityisrestrictedinmicewithlmnamutation
AT jiangmingjiang cardiomyocyteproliferativecapacityisrestrictedinmicewithlmnamutation
AT michaelparfenov cardiomyocyteproliferativecapacityisrestrictedinmicewithlmnamutation
AT stevendepalma cardiomyocyteproliferativecapacityisrestrictedinmicewithlmnamutation
AT davidconner cardiomyocyteproliferativecapacityisrestrictedinmicewithlmnamutation
AT joshuagorham cardiomyocyteproliferativecapacityisrestrictedinmicewithlmnamutation
AT davidmckean cardiomyocyteproliferativecapacityisrestrictedinmicewithlmnamutation
AT jonathangseidman cardiomyocyteproliferativecapacityisrestrictedinmicewithlmnamutation
AT christineeseidman cardiomyocyteproliferativecapacityisrestrictedinmicewithlmnamutation
AT christineeseidman cardiomyocyteproliferativecapacityisrestrictedinmicewithlmnamutation
AT yoshihikosaito cardiomyocyteproliferativecapacityisrestrictedinmicewithlmnamutation
_version_ 1721362566284836864